Position in JNJ
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$38,077,721
+$2,025,512 QoQ
Shares Held
149,930
+1.7% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
1.24%
of 13F equity value
Holder Rank
#518
of 4,664 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WESBANCO BANK INC holds $195,633,177 across 11 Drug Manufacturers - General names. JNJ ranks #2 (19.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
31,820 | $38,165,865 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
149,930 | $38,077,721 | |
| 3 | MRK |
Merck & Co., Inc.
|
280,575 | $36,053,887 | |
| 4 | AMGN |
Amgen Inc
|
88,377 | $32,003,078 | |
| 5 | ABBV |
AbbVie Inc.
|
75,720 | $19,054,180 | |
| 6 | AZN |
Astrazeneca PLC
|
68,209 | $12,933,789 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
217,215 | $12,515,927 | |
| 8 | PFE |
Pfizer Inc
|
162,515 | $3,913,360 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $38,077,721 | 149,930 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $36,052,209 | 147,489 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $30,381,501 | 146,806 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $27,742,724 | 149,621 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $22,774,566 | 149,097 | Shares | Sole | 2025-07-07 | |
| 2025-03-31 | $24,551,781 | 148,045 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $21,678,825 | 149,902 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $24,844,445 | 153,304 | Shares | Sole | 2024-10-11 | |
| 2024-06-30 | $23,102,925 | 158,066 | Shares | Sole | 2024-07-11 | |
| 2024-03-31 | $35,873,852 | 226,777 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $33,860,697 | 216,031 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $39,700,985 | 254,902 | Shares | Sole | 2023-12-11 | |
| 2023-06-30 | $43,486,074 | 262,724 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $40,553,425 | 261,635 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $40,122,690 | 227,131 | Shares | Sole | 2023-01-18 | |
| 2022-09-30 | $34,278,971 | 209,837 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $41,055,044 | 231,283 | Shares | Sole | 2022-07-18 | |
| 2022-03-31 | $41,970,544 | 236,814 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $40,442,314 | 236,408 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $37,980,923 | 235,176 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $39,396,087 | 239,141 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $40,050,779 | 243,692 | Shares | Sole | 2021-05-06 | |
| 2020-09-30 | $35,904,048 | 241,161 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $32,806,165 | 233,280 | Shares | Sole | 2020-07-14 | |
| 2020-03-31 | $30,796,010 | 234,851 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||